Non-invasive cell-free fetal DNA testing: a multicenter follow-up study of 31515 singleton pregnancies in southeastern China.
To follow up the noninvasive prenatal testing (NIPT) results of 31515 singleton pregnancies in Fujian province, southeastern China and assess its performance in low-, moderate- and high-risk pregnancies. Cell-free plasma DNA was subjected to low-coverage whole-genome sequencing. Standard Z-score analysis of the mapped sequencing reads was used to call fetal aneuploidies, including trisomies 21, 18 and 13 (T21, T18, T13) and sex chromosome aneuploidies (SCAs). NIPT positive results were confirmed by amniocentesis and karyotyping. In the study population, the positive rate of chromosomal abnormalities detected by NIPT was 1.38%. A higher rate of chromosomal abnormalities was found in the high-risk group (1.57%) compared to moderate- (1.05%) and low-risk groups (1.18%) (P < 0.05). The sensitivity and specificity was 98.96% (95/96) and 99.97% (31401/31419) for detection of T21, 100% (25/25) and 99.97% (31479/31490) for T18, 100% (7/7) and 99.97% (31500/31508) for T13 and 100% (61/61) and 99.74% (31372/31454) for SCAs. Positive predictive values (PPVs) were high for T21 (84.07%), T18 (69.44%) and moderate for T13 (46.67%) SCAs (42.66%). Our findings support the application of NIPT for reliable and accurate testing of the general population of reproductive women for clinically significant fetal aneuploidies. This article is protected by copyright. All rights reserved.